PUBLICATION

Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish

Authors
Becker, J.R., Deo, R.C., Werdich, A.A., Panàkovà, D., Coy, S., and MacRae, C.A.
ID
ZDB-PUB-110124-3
Date
2011
Source
Disease models & mechanisms   4(3): 400-410 (Journal)
Registered Authors
MacRae, Calum A., Panáková, Daniela
Keywords
none
Datasets
GEO:GSE20179
MeSH Terms
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism
  • Embryo, Nonmammalian/pathology
  • Mice
  • Troponin T/chemistry
  • Troponin T/genetics
  • Organogenesis*/drug effects
  • Amino Acid Sequence
  • Molecular Sequence Data
  • Sarcomeres/drug effects
  • Sarcomeres/pathology
  • Calcium/metabolism
  • Mutation/genetics*
  • Myocardial Contraction/drug effects
  • Cardiomyopathy, Hypertrophic/complications
  • Cardiomyopathy, Hypertrophic/genetics*
  • Cardiomyopathy, Hypertrophic/pathology*
  • Cardiomyopathy, Hypertrophic/physiopathology
  • Heart Ventricles/drug effects
  • Heart Ventricles/pathology
  • Heart Ventricles/physiopathology
  • Heart/drug effects
  • Heart/embryology*
  • Heart/physiopathology
  • Myocytes, Cardiac/metabolism
  • Myocytes, Cardiac/pathology*
  • Alternative Splicing/drug effects
  • Alternative Splicing/genetics
  • Zebrafish Proteins/chemistry
  • Zebrafish Proteins/genetics
  • Oligonucleotides, Antisense/pharmacology
  • Animals
  • Transcription, Genetic/drug effects
  • Hyperplasia/complications
  • Hyperplasia/pathology
  • Gene Expression Regulation, Developmental/drug effects
  • Zebrafish/embryology*
  • Zebrafish/genetics
  • Humans
(all 39)
PubMed
21245263 Full text @ Dis. Model. Mech.
Abstract
To assess the effects during cardiac development of mutations that cause human cardiomyopathy, we modeled a sarcomeric gene mutation in the embryonic zebrafish. We designed morpholino antisense oligonucleotides targeting the exon 13 splice donor site in the zebrafish cardiac troponin T (tnnt2) gene, in order to precisely recapitulate a human TNNT2 mutation that causes hypertrophic cardiomyopathy (HCM). HCM is a disease characterized by myocardial hypertrophy, myocyte and myofibrillar disarray, as well as an increased risk of sudden death. Similar to humans with HCM, the morphant zebrafish embryos displayed sarcomere disarray and there was a robust induction of myocardial hypertrophic pathways. Microarray analysis uncovered a number of shared transcriptional responses between this zebrafish model and a well-characterized mouse model of HCM. However, in contrast to adult hearts, these embryonic hearts developed cardiomyocyte hyperplasia in response to this genetic perturbation. The re-creation of a human disease-causing TNNT2 splice variant demonstrates that sarcomeric mutations can alter cardiomyocyte biology at the earliest stages of heart development with distinct effects from those observed in adult hearts despite shared transcriptional responses.
Genes / Markers
Figures
Figure Gallery (4 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Marker Marker Type Name
DsRed2EFGDsRed2
1 - 1 of 1
Show
Mapping